The U.S. District Court for the Northern District of Illinois Dismisses Antitrust Case Challenging Patent Thicket (Humira)

Whether behavior relating to a patent thicket presents an antitrust issue is a nuanced question. But a recent ruling involving the biologic Humira shows how not to decide these issues. This short piece discusses the court’s opinion and highlights its errors analyzing sham behavior, patent settlements, and antitrust injury

MoreLess

Year of publication:	2020
Authors:	Carrier, Michael A.
Publisher:	[S.l.] : SSRN
Subject:	USA \| United States \| Kartellrecht \| Antitrust law \| Patent \| Patentrecht \| Patent law

freely available

Full text |

More access options

Check Google Scholar

In German libraries (KVK)

I need help

Extent:	1 Online-Ressource (7 p)
Type of publication:	Book / Working Paper
Language:	English
Notes:	In: e-Competitions (No. 96364, Sept. 2020) Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments August 20, 2020 erstellt
Classification:	I18 - Government Policy; Regulation; Public Health ; K21 - Antitrust Law ; L40 - Antitrust Policy. General ; L41 - Monopolization; Horizontal Anticompetitive Practices ; L43 - Legal Monopolies and Regulation or Deregulation ; L65 - Chemicals; Rubber; Drugs; Biotechnology ; O34 - Intellectual Property Rights: National and International Issues ; O38 - Government Policy
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10014094366